Tech News Today — October 21, 2026

The intersection of technology and biology is gaining momentum, as evidenced by OpenAI's acquisition of Orchestra Bio, a move that underscores the growing interest in applying artificial intelligence to biotech. This development comes at a time when the capabilities of AI are expanding rapidly, and its applications are becoming increasingly diverse. The idea of merging physical systems with AI, often referred to as "physical AI," is also gaining traction. According to Amulya Vishwanath, a venture capitalist who previously worked at Nvidia, physical AI is currently in its "LEGO era," suggesting that we are in the early stages of building more complex and integrated systems.

As AI technologies continue to advance and find new applications, concerns about their use and potential risks are also on the rise. The US government's recent directive to federal agencies to remove China's DeepSeek AI from their systems highlights the growing scrutiny of AI tools, particularly those developed in other countries. This move reflects a broader trend of governments and organizations taking a closer look at the AI technologies they use and the potential implications of their use. As AI becomes increasingly pervasive and influential, it is likely that we will see more developments like these, as well as ongoing discussions about the benefits and risks of AI and how to manage them.

Today's signal:
• OpenAI acquires startup Orchestra Bio⁠ to beef up its biotech business (techcrunch.com)
• Ex-Nvidia-turned-VC Amulya Vishwanath: ‘Physical AI is in it’s LEGO era’ (techcrunch.com)
• US orders federal agencies to remove China’s DeepSeek AI from their systems (techcrunch.com)